Analyze Diet

Topic:Oral Administration

Oral administration in horses refers to the delivery of medications, supplements, or nutrients via the mouth. This method is commonly used in equine veterinary medicine for its practicality and ease of use. Oral formulations can include powders, pastes, or liquids, which are designed to be palatable and easily ingested by horses. The effectiveness of oral administration depends on factors such as the horse's digestive physiology, the formulation of the product, and the consistency with which it is administered. This page compiles peer-reviewed research studies and scholarly articles that explore the techniques, efficacy, and considerations of oral administration in equine care.
Folate deficiency during treatment with orally administered folic acid, sulphadiazine and pyrimethamine in a horse with suspected equine protozoal myeloencephalitis (EPM).
Equine veterinary journal    July 11, 2002   Volume 34, Issue 3 311-316 doi: 10.2746/042516402776186128
Piercy RJ, Hinchcliff KW, Reed SM.No abstract available
Prednisone per os is likely to have limited efficacy in horses.
Equine veterinary journal    July 11, 2002   Volume 34, Issue 3 283-287 doi: 10.2746/042516402776186056
Peroni DL, Stanley S, Kollias-Baker C, Robinson NE.Based on its efficacy for the treatment of human asthma, the corticosteroid prednisone is commonly used in horses for treatment of recurrent airway obstruction. However, recent studies have failed to show any benefit of prednisone tablets for the treatment of this condition. The purpose of this study was to determine why oral prednisone has poor efficacy for the treatment of heaves in horses. In a crossover study, 5 horses were given the following treatments: prednisone tablets, prednisone liquid, prednisolone tablets, prednisolone liquid and i.v. prednisolone sodium succinate (positive contro...
Pharmacokinetics of doramectin and ivermectin after oral administration in horses.
Veterinary journal (London, England : 1997)    July 3, 2002   Volume 163, Issue 2 161-167 doi: 10.1053/tvjl.2001.0624
Pérez R, Cabezas I, Godoy C, Rubilar L, Muñoz L, Arboix M, Castells G, Alvinerie M.A study was undertaken in order to compare plasma disposition kinetic parameters of doramectin (DRM) and ivermectin (IVM) in horses after oral administration. Ten crossbreed adult horses, clinically healthy, weighing 380-470 kg body weight (bw) were selected for study. Faecal examinations were performed to determine faecal parasite egg counts. Horses were allocated to two groups of five animals to provide an even distribution considering the variables sex, body weight and faecal egg count. Group I, were treated with an oral paste formulation of IVM at 0.2 mg/kg b/w and Group II, were treated w...
Pharmacokinetics of erythromycin ethylsuccinate after intragastric administration to healthy foals.
Veterinary therapeutics : research in applied veterinary medicine    July 1, 2002   Volume 3, Issue 2 189-195 
Lakritz J, Wilson WD, Marsh AE, Mihalyi JE.Plasma concentrations and pharmacokinetics of erythromycin and related compounds were determined after administration of erythromycin ethylsuccinate to six healthy male foals 3 to 5 months of age. Hay was withheld from the foals overnight and erythromycin ethylsuccinate (25 mg/kg of body weight) was administered intragastrically. Plasma erythromycin concentrations were determined at specific times after drug administration by high-performance liquid chromatography assay. Maximum peak plasma concentrations, time to maximum concentrations, area under plasma concentration versus time curves, elim...
Serum response after oral supplementation of different zinc compounds in horses.
The Journal of nutrition    June 4, 2002   Volume 132, Issue 6 Suppl 2 1769S-70S doi: 10.1093/jn/132.6.1769S
Wichert B, Kreyenberg K, Kienzle E.No abstract available
Plasma disposition, faecal excretion and in vitro metabolism of oxibendazole following oral administration in horses.
Research in veterinary science    May 11, 2002   Volume 72, Issue 1 11-15 doi: 10.1053/rvsc.2001.0520
Gokbulut C, Nolan AM, McKellar QA.Oxibendazole (OBZ) was administered to eight horses at an oral dose of 10 mg kg(-1) bodyweight each. Parent OBZ could only be detected in plasma at the 0.5 and 1.0 hours post administration sampling times and the mean maximum plasma concentration was 0.008 microg ml(-1). Parent OBZ was detected in faeces between 12 and 72 hours after administration and the highest dry faecal concentration was detected at 24 hours. An unidentified metabolite was detected in plasma between 0.5 and 72 hours. The unidentified metabolite in the plasma of treated horses corresponded to the second eluted metabolite i...
Pharmacokinetics of azithromycin in foals after i.v. and oral dose and disposition into phagocytes.
Journal of veterinary pharmacology and therapeutics    May 10, 2002   Volume 25, Issue 2 99-104 doi: 10.1046/j.1365-2885.2002.00387.x
Davis JL, Gardner SY, Jones SL, Schwabenton BA, Papich MG.The properties of azithromycin suggest that it may be an alternative to erythromycin for treatment of Rhodococcus equi pneumonia in foals. To investigate this possibility, the disposition of azithromycin in plasma, polymorphonuclear leukocytes (PMN), and alveolar cells was examined after a single administration in foals. Azithromycin suspension was administered orally (p.o.) at a dose of 10 mg/kg to five healthy 2-3-month-old foals. Two weeks later, azithromycin for injection was administered by intravenous (i.v.) infusion at a dose of 5 mg/kg to the same foals. Plasma samples were collected a...
Study of the plasma pharmacokinetics and faecal excretion of the prodrug olsalazine and its metabolites after oral administration to horses.
Journal of veterinary pharmacology and therapeutics    May 10, 2002   Volume 25, Issue 2 135-143 doi: 10.1046/j.1365-2885.2002.00395.x
Knoll U, Strauhs P, Schusser G, Ungemach FR.Olsalazine sodium (Dipentum*) has been used therapeutically against inflammatory bowel disease in human medicine as an alternative to sulphasalazine over the past 20 years. Bacteria in the colon split this prodrug into two molecules of the locally effective 5-aminosalicylic acid (5-ASA). Considering the potential therapeutic use in equine colitis, the pharmacokinetics of olsalazine (OLZ) after single oral administration to six horses at a dosage of 30 mg/kg was investigated. Plasma concentrations of OLZ, 5-ASA, and its main metabolite N-acetyl-5-aminosalicylic acid (Ac-5-ASA) were analysed by ...
Detection of morphine in blood and urine samples from horses administered poppy seeds and morphine sulfate orally.
Journal of analytical toxicology    March 28, 2002   Volume 26, Issue 2 81-86 doi: 10.1093/jat/26.2.81
Kollias-Baker C, Sams R.The objective of this study was to determine if the administration of poppy seeds to horses would result in detectable concentrations of morphine in urine and blood samples, as has been shown to occur in humans. In this study blood and urine samples were collected following administration of poppy seeds and morphine sulfate orally to four horses. Urine samples were subjected to enzyme-linked immunosorbent assay (ELISA) for the presence of morphine. All urine samples testing positive by ELISA, as well as plasma samples collected after administration of the 10-g doses of poppy seeds, were analyz...
Effects of pentoxifylline on pulmonary function and results of cytologic examination of bronchoalveolar lavage fluid in horses with recurrent airway obstruction.
American journal of veterinary research    March 26, 2002   Volume 63, Issue 3 459-463 doi: 10.2460/ajvr.2002.63.459
Léguillette R, Désévaux C, Lavoie JP.To determine the effects of pentoxifylline (PTX) administration on lung function and results of cytologic examination of bronchoalveolar lavage fluid in horses affected by recurrent airway obstruction (RAO). Methods: 10 RAO-affected horses. Methods: 6 horses were orally administered PTX (16 g) mixed with corn syrup, and 4 horses were administered corn syrup alone, twice daily for 14 days. Pulmonary function was evaluated before administration (day 0) and on days 8 and 15. Bronchoalveolar lavage (BAL) was performed on days 0 and 15. Reversibility of airway obstruction was assessed by measuring ...
Detection of fenspiride and identification of in vivo metabolites in horse body fluids by capillary gas chromatography-mass spectrometry: administration, biotransformation and urinary excretion after a single oral dose.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences    February 28, 2002   Volume 767, Issue 1 131-144 doi: 10.1016/s0378-4347(01)00556-4
Dumasia MC, Houghton E, Hyde W, Greulich D, Nelson T, Peterson J.Studies related to the in vivo biotransforrmation and urinary excretion of fenspiride hydrochloride in the horse are described. After oral administration, the drug is metabolised by both phase I functionalisation and phase II conjugation pathways. Following enzymatic deconjugation, fenspiride and its phase I metabolites were isolated from post-administration biofluids using bonded co-polymeric mixed mode solid-phase extraction cartridges to isolate the basic compounds. Following trimethylsilylation (TMS), the parent drug and metabolites were identified by capillary gas chromatography-mass spec...
Metabolism of methandrostenolone in the horse: a gas chromatographic-mass spectrometric investigation of phase I and phase II metabolism.
Journal of chromatography. B, Biomedical sciences and applications    January 31, 2002   Volume 765, Issue 1 71-79 doi: 10.1016/s0378-4347(01)00409-1
McKinney AR, Ridley DD, Suann CJ.The phase I and phase II metabolism of the anabolic steroid methandrostenolone was investigated following oral administration to a standardbred gelding. In the phase I study, metabolites were isolated from the urine by solid-phase extraction, deconjugated by acid catalysed methanolysis and converted to their O-methyloxime trimethylsilyl derivatives. GC-MS analysis indicated the major metabolic processes to be sequential reduction of the A-ring and hydroxylation at C6 and C16. In the phase II study, unconjugated, beta-glucuronidated and sulfated metabolites were fractionated and deconjugated us...
Effects of oral administration of phenylbutazone to horses on in vitro articular cartilage metabolism.
American journal of veterinary research    January 5, 2002   Volume 62, Issue 12 1916-1921 doi: 10.2460/ajvr.2001.62.1916
Beluche LA, Bertone AL, Anderson DE, Rohde C.To evaluate the effects of orally administered phenylbutazone on proteoglycan synthesis and chondrocyte inhibition by IL-1beta in articular cartilage explants of horses. Methods: 11 healthy 1- to 2-year-old horses. Methods: Horses were randomly assigned to the control (n = 5) or treated group (4.4 mg of phenylbutazone/kg of body weight, p.o., q 12 h; n = 6). Articular cartilage specimens were collected before treatment was initiated (day 0), after 14 days of treatment, and 2 weeks after cessation of treatment (day 30). Proteoglycan synthesis and stromelysin concentration in cartilage extracts ...
Oral imipramine and intravenous xylazine for pharmacologically-induced ex copula ejaculation in stallions.
Animal reproduction science    December 18, 2001   Volume 68, Issue 3-4 153-159 doi: 10.1016/s0378-4320(01)00152-x
McDonnell SM.This study is part of ongoing work toward developing pharmacological methods for enhancing and inducing ejaculation in stallions with ejaculatory dysfunction or disabilities that interfere with normal breeding behavior. The objective was to evaluate a treatment regimen involving oral imipramine followed by intravenous xylazine that, in uncontrolled field clinical trials, had shown promise for a higher rate of ejaculation and fewer side effects using a more easily obtained and administered form of imipramine. Eight stallions each underwent eight trials in which treatment consisted of imipramine...
Pharmacokinetics of fluconazole following intravenous and oral administration and body fluid concentrations of fluconazole following repeated oral dosing in horses.
American journal of veterinary research    October 11, 2001   Volume 62, Issue 10 1606-1611 doi: 10.2460/ajvr.2001.62.1606
Latimer FG, Colitz CM, Campbell NB, Papich MG.To determine the pharmacokinetics of fluconazole in horses. Methods: 6 clinically normal adult horses. Methods: Fluconazole (10 mg/kg of body weight) was administered intravenously or orally with 2 weeks between treatments. Plasma fluconazole concentrations were determined prior to and 10, 20, 30, 40, and 60 minutes and 2, 4, 6, 8, 10, 12, 24, 36, 48, 60, and 72 hours after administration. A long-term oral dosing regimen was designed in which all horses received a loading dose of fluconazole (14 mg/kg) followed by 5 mg/kg every 24 hours for 10 days. Fluconazole concentrations were determined i...
Safety of an oral chondroprotective agent in horses.
Veterinary therapeutics : research in applied veterinary medicine    October 1, 2001   Volume 2, Issue 4 345-353 
Kirker-Head CA, Kirker-Head RP.Six healthy, adult female horses were administered five times the minimum maintenance dose of an oral low-molecular-weight chondroitin sulfate, glucosamine HCl, and manganese ascorbate chondroprotective agent (Cosequin; Nutramax Laboratories, Inc., Edgewood, MD) daily for 35 days. Hematology, serum biochemistry, and synovial fluid parameters were assessed twice prior to administering the product and again at the end of the treatment period. Physical examinations performed daily throughout the study showed no abnormal clinical changes attributable to the product. All hematologic parameters meas...
Plasma pharmacokinetics and faecal excretion of ivermectin, doramectin and moxidectin following oral administration in horses.
Equine veterinary journal    September 18, 2001   Volume 33, Issue 5 494-498 doi: 10.2746/042516401776254835
Gokbulut C, Nolan AM, McKellar QA.The present study was carried out to investigate whether the pharmacokinetics of avermectins or a milbemycin could explain their known or predicted efficacy in the horse. The avermectins, ivermectin (IVM) and doramectin (DRM), and the milbemycin, moxidectin (MXD), were each administered orally to horses at 200 microg/kg bwt. Blood and faecal samples were collected at predetermined times over 80 days (197 days for MXD) and 30 days, respectively, and plasma pharmacokinetics and faecal excretion determined. Maximum plasma concentrations (Cmax) (IVM: 21.4 ng/ml; DRM: 21.3 ng/ml; MXD: 30.1 ng/ml) w...
GC-MS characterization of urinary metabolites and changes of ethisterone and testosterone profile after oral administration of danazol in equine.
Journal of veterinary pharmacology and therapeutics    July 10, 2001   Volume 24, Issue 2 147-153 doi: 10.1046/j.1365-2885.2001.00317.x
Kim JY, Choi MH, Kim SJ, Kyong JB, Chung BC.No abstract available
Safety of ponazuril 15% oral paste in horses.
Veterinary therapeutics : research in applied veterinary medicine    July 1, 2001   Volume 2, Issue 3 223-231 
Kennedy T, Campbell J, Selzer V.Ponazuril, a triazine-derivative compound, is proposed as a treatment for equine protozoal myeloencephalitis caused by Sarcocystis neurona. Ponazuril 15% oral paste was administered to 24 horses at 0, 10, or 30 mg/kg body weight for either 28 or 56 days, representing zero, two, and six times the proposed dosage rate and one and two times the recommended duration of treatment, respectively. Serum chemistry analysis, coagulation profile, and hematology measurements were performed weekly and necropsy evaluations, including histopathology, were conducted for all animals at the end of the study. Mi...
Cerebrospinal fluid and serum concentrations of ponazuril in horses.
Veterinary therapeutics : research in applied veterinary medicine    July 1, 2001   Volume 2, Issue 3 232-237 
Furr M, Kennedy T.Ponazuril was administered orally to 10 adult horses at 5 mg/kg body weight, once a day for 28 days. Blood was collected once a week from each horse from Days 0 through 35, daily from Days 35 through 42, and on Day 49. Cerebrospinal fluid (CSF) was also collected once a week from Day 0 through Day 49. Concentrations of ponazuril in the serum and CSF were determined, and pharmacokinetic calculations were performed. Ponazuril was readily absorbed following oral administration; and after 7 days of dosing, the serum concentration was 4.33 +/- 1.10 mg/L, and the mean CSF concentration was 0.162 +/-...
Determination of oral dosage and pharmacokinetic analysis of flecainide in horses.
The Journal of veterinary medical science    June 20, 2001   Volume 63, Issue 5 511-514 doi: 10.1292/jvms.63.511
Ohmura H, Hiraga A, Aida H, Takahashi T, Nukada T.To determine oral dosage and to evaluate the pharmacokinetics in horses of orally administered flecainide, an antiarrhythmic drug, the correlations between its plasma concentration and PR, QRS and QT intervals in equine electrocardiograms (ECG) were investigated. Six healthy horses were administered a randomly ordered dose of 4 or 6 mg/kg of flecainide acetate. The ECG was monitored (heart rate (HR), PR, QRS, and QT intervals) and blood was taken at timed intervals to measure the plasma flecainide concentrations pre- and post-administration. The maximum plasma concentration reached 1014+/-285 ...
Clenbuterol in the horse: confirmation and quantitation of serum clenbuterol by LC-MS-MS after oral and intratracheal administration.
Journal of analytical toxicology    June 2, 2001   Volume 25, Issue 4 280-287 doi: 10.1093/jat/25.4.280
Lehner AF, Harkins JD, Karpiesiuk W, Woods WE, Robinson NE, Dirikolu L, Fisher M, Tobin T.Clenbuterol is a beta2 agonist/antagonist bronchodilator, and its identification in post-race samples may lead to sanctions. The objective of this study was to develop a specific and highly sensitive serum quantitation method for clenbuterol that would allow effective regulatory control of this agent in horses. Therefore, clenbuterol-d9 was synthesized for use as an internal standard, an automated solid-phase extraction method was developed, and both were used in conjunction with a multiple reaction monitoring liquid chromatography-tandem mass spectrometry (LC-MS-MS) method to allow unequivoca...
Pharmacokinetic disposition and faecal excretion of pyrantel embonate following oral administration in horses.
Journal of veterinary pharmacology and therapeutics    May 12, 2001   Volume 24, Issue 1 77-79 doi: 10.1046/j.1365-2885.2001.00305.x
Gokbulut C, Nolan AM, McKellar QA.No abstract available
Disposition, elimination, and bioavailability of phenytoin and its major metabolite in horses.
American journal of veterinary research    May 1, 2001   Volume 62, Issue 4 483-489 doi: 10.2460/ajvr.2001.62.483
Soma LR, Uboh CE, Guan F, Birks EK, Teleis DC, Rudy JA, Tsang DS, Watson AO.To determine pharmacokinetics and excretion of phenytoin in horses. Methods: 6 adult horses. Methods: Using a crossover design, phenytoin was administered (8.8 mg/kg of body weight, IV and PO) to 6 horses to determine bioavailability (F). Phenytoin also was administered orally twice daily for 5 days to those same 6 horses to determine steady-state concentrations and excretion patterns. Blood and urine samples were collected for analysis. Results: Mean (+/- SD) elimination half-life following a single IV or PO administration was 12.6+/-2.8 and 13.9+/-6.3 hours, respectively, and was 11.2+/-4.0 ...
The metabolism of norethandrolone in the horse: characterization of 16-, 20- and 21-oxygenated metabolites by gas chromatography/mass spectrometry.
Journal of mass spectrometry : JMS    April 5, 2001   Volume 36, Issue 2 145-150 doi: 10.1002/jms.111
McKinney AR, Ridley DD, Suann CJ.After oral administration to a thoroughbred gelding, the anabolic steroid norethandrolone was converted into a complex mixture of oxygenated metabolites. These metabolites were extracted from the urine, deconjugated by methanolysis and converted to their O-methyloxime trimethylsilyl derivatives. Gas chromatographic/mass spectrometric analysis indicated the major metabolites to be 19-norpregnane-3,16,17-triols, 19-norpregnane-3,17,20-triols and 3,17-dihydroxy-19-norpregnan-21-oic acids. Some minor metabolites were also detected.
Pharmacokinetics of the bovine formulation of enrofloxacin (Baytril 100) in horses.
Veterinary therapeutics : research in applied veterinary medicine    April 1, 2001   Volume 2, Issue 2 129-134 
Boeckh S, Buchanan C, Boeckh A, Wilkie S, Davis C, Buchanan T, Boothe D.Following approval of a concentrated injectable formulation of enrofloxacin for cattle (Baytril 100 Injectable, Bayer Corp. Agricultural Division, Shawnee Mission, KS), equine practitioners have started administering this preparation both parenterally and orally to horses, despite the lack of pharmacokinetic data in this species. Six healthy horses received enrofloxacin at 7.5 mg/kg both orally and intravenously, with the sequence being randomly assigned and at least 1 week of washout allowed between administrations. Blood samples were collected from each horse at various intervals after drug ...
Oral treatment with a nutraceutical (Cosequin) for ameliorating signs of navicular syndrome in horses.
Veterinary therapeutics : research in applied veterinary medicine    April 1, 2001   Volume 2, Issue 2 148-159 
Hanson RR, Brawner WR, Blaik MA, Hammad TA, Kincaid SA, Pugh DG.Fourteen horses with a progressive forelimb lameness of 3 to 12 months' duration, diagnosed as navicular syndrome, were selected from clinical cases admitted to Auburn University Equine Hospital for evaluation of the efficacy of an orally administered nutraceutical (Cosequin, Nutramax Laboratories, Inc., Edgewood, MD) for ameliorating clinical signs associated with naturally occurring navicular syndrome. Horses were randomly allocated to treatment with the nutraceutical or a placebo. Treatment was five scoops (16.5 g) of powder twice daily in the feed. The test group (n = 8) received a patente...
Effect of oral administration of excessive iron in adult ponies.
Journal of the American Veterinary Medical Association    February 24, 2001   Volume 218, Issue 3 400-404 doi: 10.2460/javma.2001.218.400
Pearson EG, Andreasen CB.To evaluate the potential of excess dietary iron to cause hepatic lesions similar to those described in horses with suspected iron toxicosis or hemochromatosis. Methods: Prospective study. Methods: 6 adult male ponies. Methods: 4 ponies received 50 mg of iron/kg (22.7 mg/lb) of body weight each day by oral administration of ferrous sulfate, which contained 20% elemental iron; 2 ponies received only the carrier (applesauce). Complete blood counts, serum biochemical analyses, and hepatic tissue biopsies were performed, and serum iron concentrations were measured. Blood and tissue samples were ob...
Pharmacokinetics of metronidazole in horses after intravenous, rectal and oral administration.
Journal of veterinary pharmacology and therapeutics    February 13, 2001   Volume 23, Issue 6 353-357 doi: 10.1046/j.1365-2885.2000.00294.x
Steinman A, Gips M, Lavy E, Sinay I, Soback S.Metronidazole pharmacokinetics in horses was studied after intravenous (i.v.), rectal (p.r.) and oral (p.o.) administration at 20 mg/kg using a triple crossover study design. Metronidazole mean+/-SD half-life was 196+/-39, 212+/-30 and 240+/-65 min after i.v., p.r. and p.o. administration, respectively. The metronidazole clearance was 2.8 (mL/min/kg) and the volume of distribution at steady state was 0.68 L/kg. The pharmacokinetic parameters calculated for metronidazole after administration of the drug by the various routes showed that bioavailability (74+/-18 vs. 30+/-9%) and maximum serum co...
Faecal excretion profile of moxidectin and ivermectin after oral administration in horses.
Veterinary journal (London, England : 1997)    January 9, 2001   Volume 161, Issue 1 85-92 doi: 10.1053/tvjl.2000.0521
Pérez R, Cabezas I, Sutra JF, Galtier P, Alvinerie M.A study was undertaken to evaluate and compare faecal excretion of moxidectin and ivermectin in horses after oral administration of commercially available preparations. Ten clinically healthy adult horses, weighing 390-446 kg body weight (b.w.), were allocated to two experimental groups. Group I was treated with an oral gel formulation of moxidectin at the manufacturer's recommended therapeutic dose of 0.4 mg/kg b.w. Group II was treated with an oral paste formulation of ivermectin at the recommended dose of 0.2 mg/kg b.w. Faecal samples were collected at different times between 1 and 75 days ...
1 15 16 17 18 19 26